Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Antigen depot is not required for alum adjuvanticity.

Hutchison S, Benson RA, Gibson VB, Pollock AH, Garside P, Brewer JM.

FASEB J. 2012 Mar;26(3):1272-9. doi: 10.1096/fj.11-184556. Epub 2011 Nov 21.

2.

Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro.

Ghimire TR, Benson RA, Garside P, Brewer JM.

Immunol Lett. 2012 Sep;147(1-2):55-62. doi: 10.1016/j.imlet.2012.06.002. Epub 2012 Jun 23.

3.

Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells.

Kamath AT, Valenti MP, Rochat AF, Agger EM, Lingnau K, von Gabain A, Andersen P, Lambert PH, Siegrist CA.

Eur J Immunol. 2008 May;38(5):1247-56. doi: 10.1002/eji.200737889.

4.

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.

Kool M, Soullié T, van Nimwegen M, Willart MA, Muskens F, Jung S, Hoogsteden HC, Hammad H, Lambrecht BN.

J Exp Med. 2008 Apr 14;205(4):869-82. doi: 10.1084/jem.20071087. Epub 2008 Mar 24.

5.

Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells.

McKee AS, Burchill MA, Munks MW, Jin L, Kappler JW, Friedman RS, Jacobelli J, Marrack P.

Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1122-31. doi: 10.1073/pnas.1300392110. Epub 2013 Feb 27.

6.

Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen.

Wikstrom ME, Batanero E, Smith M, Thomas JA, von Garnier C, Holt PG, Stumbles PA.

J Immunol. 2006 Jul 15;177(2):913-24.

7.

Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants.

Yang CW, Strong BS, Miller MJ, Unanue ER.

J Immunol. 2010 Sep 1;185(5):2927-34. doi: 10.4049/jimmunol.1001289. Epub 2010 Aug 2.

8.

Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses.

Boscardin SB, Hafalla JC, Masilamani RF, Kamphorst AO, Zebroski HA, Rai U, Morrot A, Zavala F, Steinman RM, Nussenzweig RS, Nussenzweig MC.

J Exp Med. 2006 Mar 20;203(3):599-606. Epub 2006 Feb 27.

9.

The Syk-NFAT-IL-2 Pathway in Dendritic Cells Is Required for Optimal Sterile Immunity Elicited by Alum Adjuvants.

Khameneh HJ, Ho AW, Spreafico R, Derks H, Quek HQ, Mortellaro A.

J Immunol. 2017 Jan 1;198(1):196-204. Epub 2016 Nov 28.

10.

Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines.

Disis ML, Bernhard H, Shiota FM, Hand SL, Gralow JR, Huseby ES, Gillis S, Cheever MA.

Blood. 1996 Jul 1;88(1):202-10.

11.

Soluble antigen traffics rapidly and selectively from the corneal surface to the eye draining lymph node and activates T cells when codelivered with CpG oligonucleotides.

Dang Z, Kuffová L, Liu L, Forrester JV.

J Leukoc Biol. 2014 Mar;95(3):431-40. doi: 10.1189/jlb.0612294. Epub 2013 Dec 2.

12.

APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.

Warren TL, Bhatia SK, Acosta AM, Dahle CE, Ratliff TL, Krieg AM, Weiner GJ.

J Immunol. 2000 Dec 1;165(11):6244-51.

13.

CD69 does not affect the extent of T cell priming.

Alari-Pahissa E, Notario L, Lorente E, Vega-Ramos J, Justel A, López D, Villadangos JA, Lauzurica P.

PLoS One. 2012;7(10):e48593. doi: 10.1371/journal.pone.0048593. Epub 2012 Oct 30.

14.

Coadministration of antigen-conjugated and free CpG: effects of in vitro and in vivo interactions in a murine model.

Herbáth M, Szekeres Z, Kövesdi D, Papp K, Erdei A, Prechl J.

Immunol Lett. 2014 Aug;160(2):178-85. doi: 10.1016/j.imlet.2014.02.007. Epub 2014 Feb 22.

PMID:
24565977
15.
16.

Antigen delivery for cross priming via the emulsion vaccine adjuvants.

Shen SS, Yang YW.

Vaccine. 2012 Feb 21;30(9):1560-71. doi: 10.1016/j.vaccine.2011.12.120. Epub 2012 Jan 9.

PMID:
22230588
17.

A comparative study of stress-mediated immunological functions with the adjuvanticity of alum.

Wang Y, Rahman D, Lehner T.

J Biol Chem. 2012 May 18;287(21):17152-60. doi: 10.1074/jbc.M112.347179. Epub 2012 Apr 3.

18.

Comparison of PLA microparticles and alum as adjuvants for H5N1 influenza split vaccine: adjuvanticity evaluation and preliminary action mode analysis.

Zhang W, Wang L, Liu Y, Chen X, Li J, Yang T, An W, Ma X, Pan R, Ma G.

Pharm Res. 2014 Apr;31(4):1015-31. doi: 10.1007/s11095-013-1224-z. Epub 2013 Oct 30.

PMID:
24170280
19.

Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.

Robson NC, Donachie AM, Mowat AM.

Eur J Immunol. 2008 May;38(5):1238-46. doi: 10.1002/eji.200737758.

20.

Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.

Mochizuki S, Morishita H, Kobiyama K, Aoshi T, Ishii KJ, Sakurai K.

J Control Release. 2015 Dec 28;220(Pt A):495-502. doi: 10.1016/j.jconrel.2015.11.008. Epub 2015 Nov 10.

PMID:
26562685

Supplemental Content

Support Center